Literature DB >> 3931611

Clostridium difficile colitis mimicking acute peritonitis.

M S Drapkin, M G Worthington, T W Chang, S A Razvi.   

Abstract

Five patients receiving penicillin V potassium or a cephalosporin antibiotic for 18 hours to 22 days developed fever, marked leukocytosis, and signs and symptoms that suggested right-lower-quadrant peritoneal irritation. All underwent emergency laparotomy, at which dilatation and inflammation of the ascending colon were found. Only one of the patients had profuse diarrhea, and two patients had no diarrhea prior to laparotomy. Postoperatively, Clostridium difficile colitis was diagnosed by stool toxin assay and was confirmed in one case by proctosigmoidoscopic biopsy results. Antibiotic-associated colitis must be considered in any patient who develops peritoneal signs while or after receiving antibiotics. Over a two-year period, the "acute abdomen" presentation accounted for 5.2% of all patients with C difficile colitis at our institutions. Early proctosigmoidoscopy or stool examination for C difficile or its toxin may avoid unnecessary laparotomy in such patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931611     DOI: 10.1001/archsurg.1985.01390350097021

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  4 in total

Review 1.  Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Authors:  Edward C Oldfield; Edward C Oldfield; David A Johnson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

Review 2.  The role of surgery in pseudomembranous enterocolitis.

Authors:  Y K Viswanath; C D Griffiths
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

Review 3.  Clostridium difficile Infection and Fecal Microbiota Transplant.

Authors:  Alyssa Liubakka; Byron P Vaughn
Journal:  AACN Adv Crit Care       Date:  2016-07

4.  Clostridium difficile infection.

Authors:  Stephen A Geller; Fernando P F de Campos
Journal:  Autops Case Rep       Date:  2014-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.